The earnings call highlights several positive developments, such as improved gross margins, completion of the CAPTAIN trial, and the introduction of the TULSA-AI software. However, these are balanced by significant financial challenges, including stagnant revenue, increased operating expenses, and sales delays. The company remains optimistic about future growth, particularly with its sales pipeline and new software introduction.

Company Guidance

During the Profound Medical Second Quarter 2025 Financial Results Conference Call, the company provided guidance indicating confidence in achieving 70% to 75% revenue growth in 2025 compared to 2024, despite a current shortfall in Q2 revenues. The company's revenue for Q2 2025 was $2.2 million, with $1.6 million from recurring revenue and $650,000 from a one-time sale of capital equipment. Profound Medical reported a net loss of $15.7 million, or $0.52 per share, for Q2 2025, compared to a net loss of $6.9 million, or $0.28 per share, in Q2 2024. The company had $35.2 million in cash as of June 30, 2025. The transition from a placement model to a capital model is expected to be back-end loaded, with a pipeline of approximately 500 prospects for the TULSA-PRO system, including 80 qualified leads. Profound is also focusing on expanding its installed base in the U.S., with plans to grow the number of active TULSA sites from 60 to at least 75 by the end of the year.

Gross Margin Improvement

Gross margin in Q2 2025 was 73% compared to 64% in Q2 2024, indicating improved profitability.

Completion of CAPTAIN Trial

The CAPTAIN trial is fully recruited and all patient treatments are complete, which is crucial for gaining professional society treatment guidelines and positive reimbursement coverage.

Introduction of TULSA-AI Volume Reduction Software

The pilot release of the new TULSA-AI volume reduction software was successful, allowing for faster procedures in BPH treatments and improving efficiency.

Increased TULSA-PRO Pipeline

The pipeline for TULSA-PRO sales includes 500 prospects, with 80 in advanced stages, supporting expectations for better second-half performance.

Profound Medical (TSE:PRN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:PRN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	-0.54 / -	-0.525	―	―	―
Aug 14, 2025	2025 (Q2)	-0.51 / -0.72	-0.387	-85.71% (-0.33)	―	―
May 08, 2025	2025 (Q1)	-0.39 / -0.50	-0.359	-38.46% (-0.14)	―	―
Mar 06, 2025	2024 (Q4)	-0.44 / -0.28	-0.58	52.38% (+0.30)	―	―
Nov 07, 2024	2024 (Q3)	-0.41 / -0.52	-0.359	-46.15% (-0.17)	―	―
Aug 08, 2024	2024 (Q2)	-0.39 / -0.39	-0.483	20.00% (+0.10)	―	―
May 09, 2024	2024 (Q1)	-0.41 / -0.36	-0.442	18.75% (+0.08)	―	―
Mar 07, 2024	2023 (Q4)	-0.43 / -0.58	-0.635	8.70% (+0.06)	―	―
Nov 02, 2023	2023 (Q3)	-0.47 / -0.36	-0.331	-8.33% (-0.03)	―	―
Aug 09, 2023	2023 (Q2)	-0.48 / -0.48	-0.387	-25.00% (-0.10)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TSE:PRN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 14, 2025	C$7.54	C$5.96	-20.95%
May 08, 2025	C$6.90	C$6.42	-6.96%
Mar 06, 2025	C$10.34	C$9.91	-4.16%
Nov 07, 2024	C$12.35	C$11.98	-3.00%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Profound Medical (TSE:PRN) report earnings?

Profound Medical (TSE:PRN) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).

What is Profound Medical (TSE:PRN) earnings time?

Profound Medical (TSE:PRN) earnings time is at Oct 30, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TSE:PRN EPS forecast?

TSE:PRN EPS forecast for the fiscal quarter 2025 (Q3) is -0.54.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing